✦ LIBER ✦

Adjuvant therapy of stage II breast cancer

✍ Scribed by Charles A. Hubay; Olof H. Pearson; James S. Marshall; Thomas A. Stellato; Robert S. Rhodes; Sara M. DeBanne; Judah Rosenblatt; Edward G. Mansour; Robert E. Hermann; James C. Jones; William J. Flynn; Charles Eckert; William L. McGuire

Publisher: Springer US
Year: 1981
Tongue: English
Weight: 606 KB
Volume: 1
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01807895

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant therapy of stage II breast canc

Adjuvant therapy of stage II breast cancer

✍ Paul P. Carbone 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

Parametric survival analysis of adjuvant

Parametric survival analysis of adjuvant therapy for stage II breast cancer

✍ John W. Gamel; Robert L. Vogel; Pinuccia Valagussa; Gianni Bonadonna 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Meta-analysis of the second collaborativ

Meta-analysis of the second collaborative study of adjuvant chemoendocrine therapy for breast cancer (acetbc) in patients with stage ii, estrogen-receptor-positive breast cancer

✍ Minoru Yoshida; Osahiko Abe; Junichi Uchino; Kaneo Kikuchi; Rikiya Abe; Kohji En 📂 Article 📅 1997 🏛 Springer Japan 🌐 English ⚖ 734 KB

Ten-year results of a randomized trial o

Ten-year results of a randomized trial on adjuvant chemo-endocrine therapy with tamoxifen for stage II breast cancer

✍ Yoshinobu Hata; Hiromasa Takahashi; Satoru Todo; Minoru Okazaki; Kazuaki Asaishi 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 478 KB

Adjuvant chemotherapy, antiestrogen ther

Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trial

✍ Charles A. Hubay; Olof H. Pearson; James S. Marshall; Robert S. Rhodes; Sara M. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

Safety of zoledronic acid and incidence

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

✍ R. Coleman; E. Woodward; J. Brown; D. Cameron; R. Bell; D. Dodwell; M. Keane; M. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 339 KB